Review
Open access
Sep 2026
Recent Advances in Chronic Myeloid Leukaemia (CML): Emerging Molecular and Immunotherapeutic Targets.
The pivotal role of LSCs in disease progression and relapse is highlighted, potential molecular and epigenetic regulators as new targets for intervention are evaluated, and the development of combination treatment strategies to improve TFR rates and move towards curative outcomes is supported.
Jing-Yi Dai, Pan-Pan Zheng, Jian Liu et al.
· Frontiers in Bioscience · 0 citations